Key facts
- Notable investors include Big Bang | Startup Challenge, The Founder Games, Accelerate Izmir, ITK Ventures, Innogate — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Uniqgene
- ·The full record, as it builds
Funding rounds
No funding rounds for Uniqgene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uniqgene
Operator of a genetic testing and analysis company intended to provide personalized health insights. The company offers a variety of advanced genetic testing services, including whole exome and genome sequencing and bioinformatics analysis, enabling customers to gain personalized insights into their health, ancestry, and potential disease risks, thus allowing for informed lifestyle and medical decisions.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2018
- Website
- uniqgene.com/
- Ownership
- Privately Held (backing)
Uniqgene doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uniqgene shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uniqgene in its N-PORT filings yet. We sweep new filings monthly.